Find your next paid study

Bettina MittendorferNCT06571474

~$10 – $1,125

ObesityNonalcoholic Fatty LiverDiabetes Type 2+1 more

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity-Associated Diseases

The goal of this study is to evaluate the role of transcription factor EB (TFEB) in adipose (fat) tissue macrophages (ATM) in regulating adipose tissue and sys…

Bettina MittendorferNCT06335771

~$10 – $7,500

Stressor, IndividualAlcohol ImpairmentSleep Deprivation+1 more

Neurobehavioral Changes Following Spaceflight Stressors

This study aims to investigate the impairing effects of known central nervous system (CNS) stressors in a controlled environment in order to predict and mitiga…

University of PennsylvaniaNCT07293494

Ketogenic DietAlcohol DrinkingAlcohol Use Disorder+2 more

Effects of Ketogenic Diet on Alcohol Intoxication

The research study is being conducted to better understand the effects of ketosis on brain functioning and the acute effects of alcohol. Participants will be a…

University of PennsylvaniaNCT07602270

Binge Alcohol ConsumptionSuicidal Ideation

Randomized Controlled Feasibility Trial of an Avatar Guided Intervention for Young Adults Seen in the Emergency Department With Alcohol Use Problems and Suicidal Thoughts

The goal of this clinical trial is to learn whether a novel digital avatar (virtual coach) support program can help emerging adults ages 18-29 who present to t…

University of Massachusetts, WorcesterNCT07418047

Phase 2

A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults With Alcohol-related Liver Disease (ALD)

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.

Liver Diseases, Alcoholic

GlaxoSmithKlineNCT06613698

~$10 – $7,500

Underage DrinkingDrinking, TeenAdolescent Alcohol Use

A Randomized Clinical Trial: Examining the Efficacy of eCHECKUP TO GO Combined With a Brief Parent-based Intervention to Reduce High School Student Drinking

Underage drinking is a significant problem in the United States. While past research supports the efficacy of interventions in delaying the initiation of alcoh…

Binghamton UniversityNCT07086508

Alcohol Use DisorderAlcohol-related Liver Disease

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease (IMPACT-ALD): Aim 1

This protocol describes a randomized controlled trial testing the effectiveness and implementability of the CHESS Health Connections smartphone application amo…

University of Wisconsin, MadisonNCT06305624

Phase 4

A Prospective Multicenter International Randomized Controlled Trial Comparing Surgical and Medical Therapies in the Treatment of Advanced Metabolic Dysfunction Associated Steatohepatitis

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health con…

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)+2 more

The Cleveland ClinicNCT06374875

Phase 1

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD), a Phase 1b Study

Background: Glucagon-like peptide 1 (GLP-1) agonist drugs are used to treat diabetes and aid weight loss. They may also help reduce cravings for drugs and alc…

Alcohol Use Disorder (AUD)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT07559500

~$10 – $5,625

Alcohol Use, UnspecifiedRelationship, SocialDepression, Anxiety

User Testing and Feasibility Study of an Intervention Addressing Young Adults' Experiences With Alcohol and Romantic Relationships

Whole Selves is a novel print and online intervention using motivational interviewing principles and personalized feedback to address young adults' alcohol use…

Boston UniversityNCT06392542

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis and improvement of liver-related clini…

Non-alcoholic Fatty Liver Disease